pro Caspase-1+p10+p12 Antibody (Rabbit mAb) [H3L1]

Catalog No.: F1539

    Application: Reactivity:
    • Lane 1: THP-1 (LPS, 0.1 µg/mL, 3 h; ATP, 5 mM, 15 min)
    1/
    サイズ (液体) 価格(税別) 在庫状況
    JPY 17300 国内在庫なし(納期7~10日)
    JPY 39900 国内在庫なし(納期7~10日)
    JPY 59900 お問い合わせ

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp
    よく尋ねられる質問

    キーポイント

    procaspase-1遺伝子の転写産物では選択的スプライシングが生じ、複数の異なるアイソフォームが産生される。各アイソフォームのタンパク質分子量に差があるため、タンパク質電気泳動において30~45 kDaの領域に複数の特異的バンドが認められる。50 kDaのバンドは最も広く発現するアイソフォームであるcaspase-1 αに対応する。

    使用情報

    Dilution
    1:1000
    1:100
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    45 kDa 10 kDa, 30-45kDa, 50kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Rat lung tissue; Human fetal lung tissue; Rat spleen tissue; Mouse spleen tissue; Mouse brain tissue; Rat brain tissue; RAW 264.7 cells; THP-1 cells; J774A.1 cells
    ネガティブコントロール NCI-H1299 cells; A549 cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    pro Caspase-1+p10+p12 Antibody (Rabbit mAb) [H3L1] detects endogenous levels of total pro Caspase-1, p10, p12 protein.
    タンパク質の局在
    細胞膜、細胞質、細胞内膜系
    Uniprot ID
    P29466
    Clone
    H3L1
    Synonym(s)
    IL1BC, IL1BCE, CASP1, Caspase-1, CASP-1, Interleukin-1 beta convertase, Interleukin-1 beta-converting enzyme, p45, IL-1BC, ICE, IL-1 beta-converting enzyme
    Background
    Pro caspase‑1 is the inactive zymogen of the inflammatory caspase‑1 that contains an N‑terminal caspase recruitment domain (CARD) followed by a large catalytic subunit (p20) and a small subunit (p10/p12 region), and the term “pro caspase‑1 + p10 + p12” refers to detection of both the full‑length precursor and its processed small subunits that together define the activation status of caspase‑1 within inflammasome pathways. The zymogen resides in the cytosol of myeloid and other cells and is recruited via CARD–CARD interactions to inflammasome platforms built by pattern‑recognition receptors such as NLRP3, NLRC4, AIM2, or other NLRs and adaptor ASC, which bring multiple pro caspase‑1 molecules into proximity and promote autoproteolytic processing at defined internal aspartate residues to generate p20 and p10/p12 fragments that assemble into an active heterotetramer. The active enzyme cleaves the pro‑forms of IL‑1β and IL‑18 to their mature secreted cytokines and also processes gasdermin D to release its N‑terminal pore‑forming domain, so caspase‑1 activation via its p20/p10 complex couples pathogen‑ or damage‑associated molecular pattern sensing to secretion of key pro‑inflammatory cytokines and to pyroptotic lytic cell death that facilitates pathogen clearance and inflammatory signaling. Beyond canonical inflammasomes, caspase‑1 participates in alternative activation routes, interacts with RIP2 and NF‑κB signaling components, and can influence glycolytic enzymes, caspase‑7 activation, and unconventional protein secretion, indicating broader roles in metabolic adaptation, cell survival, and non‑classical secretion in a context‑dependent manner. The balance between the unprocessed pro form and the p10/p12‑containing active subunits therefore provides a direct biochemical readout of inflammasome engagement and caspase‑1 activation state in tissues and experimental systems, and antibodies that recognize epitopes present in pro caspase‑1 and in the p10/p12 region allow detection of both pools to monitor zymogen availability and activation‑associated cleavage within a single assay. Dysregulated caspase‑1 activity contributes to autoinflammatory and inflammatory diseases, including cryopyrin‑associated periodic syndromes, gout, rheumatoid arthritis, inflammatory bowel disease, obesity‑associated metabolic disorders, cardiovascular disease, and some cancers, through excessive IL‑1β/IL‑18 production and pyroptosis, while insufficient activation impairs host defense against bacterial and viral infections.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください